nodes	percent_of_prediction	percent_of_DWPC	metapath
Tretinoin—CYP3A7—Cyclosporine—focal segmental glomerulosclerosis	0.136	0.234	CbGbCtD
Tretinoin—CYP3A7-CYP3A51P—Cyclosporine—focal segmental glomerulosclerosis	0.136	0.234	CbGbCtD
Tretinoin—CYP3A5—Cyclosporine—focal segmental glomerulosclerosis	0.102	0.176	CbGbCtD
Tretinoin—CYP2C8—Cyclosporine—focal segmental glomerulosclerosis	0.0983	0.169	CbGbCtD
Tretinoin—CYP2C9—Cyclosporine—focal segmental glomerulosclerosis	0.0686	0.118	CbGbCtD
Tretinoin—CYP3A4—Cyclosporine—focal segmental glomerulosclerosis	0.0399	0.0685	CbGbCtD
Tretinoin—GPRC5A—kidney—focal segmental glomerulosclerosis	0.0182	0.183	CbGeAlD
Tretinoin—Septicemia—Cyclosporine—focal segmental glomerulosclerosis	0.00817	0.0353	CcSEcCtD
Tretinoin—ALDH1A2—nephron tubule—focal segmental glomerulosclerosis	0.00804	0.0808	CbGeAlD
Tretinoin—ALDH1A2—cortex of kidney—focal segmental glomerulosclerosis	0.00688	0.0691	CbGeAlD
Tretinoin—CYP4A11—kidney—focal segmental glomerulosclerosis	0.00682	0.0685	CbGeAlD
Tretinoin—CRABP1—cortex of kidney—focal segmental glomerulosclerosis	0.00664	0.0667	CbGeAlD
Tretinoin—CYP4A11—cortex of kidney—focal segmental glomerulosclerosis	0.00664	0.0667	CbGeAlD
Tretinoin—Benign intracranial hypertension—Cyclosporine—focal segmental glomerulosclerosis	0.00631	0.0273	CcSEcCtD
Tretinoin—Skin infection—Cyclosporine—focal segmental glomerulosclerosis	0.00614	0.0266	CcSEcCtD
Tretinoin—RXRA—kidney—focal segmental glomerulosclerosis	0.00614	0.0616	CbGeAlD
Tretinoin—ALDH1A1—nephron tubule—focal segmental glomerulosclerosis	0.00585	0.0587	CbGeAlD
Tretinoin—Papilloedema—Cyclosporine—focal segmental glomerulosclerosis	0.00583	0.0252	CcSEcCtD
Tretinoin—Renal tubular necrosis—Cyclosporine—focal segmental glomerulosclerosis	0.00519	0.0225	CcSEcCtD
Tretinoin—ALDH1A1—kidney—focal segmental glomerulosclerosis	0.00514	0.0516	CbGeAlD
Tretinoin—ALDH1A1—cortex of kidney—focal segmental glomerulosclerosis	0.00501	0.0502	CbGeAlD
Tretinoin—RXRG—Adipogenesis—ZMPSTE24—focal segmental glomerulosclerosis	0.00488	0.0565	CbGpPWpGaD
Tretinoin—RARA—Adipogenesis—ZMPSTE24—focal segmental glomerulosclerosis	0.00458	0.0531	CbGpPWpGaD
Tretinoin—GPRC5A—Integrated Pancreatic Cancer Pathway—PIAS1—focal segmental glomerulosclerosis	0.0045	0.0521	CbGpPWpGaD
Tretinoin—RARA—kidney—focal segmental glomerulosclerosis	0.00423	0.0425	CbGeAlD
Tretinoin—CYP3A7-CYP3A51P—nephron tubule—focal segmental glomerulosclerosis	0.00416	0.0417	CbGeAlD
Tretinoin—ALDH1A2—Vitamin A and Carotenoid Metabolism—LPL—focal segmental glomerulosclerosis	0.00404	0.0468	CbGpPWpGaD
Tretinoin—Pancreatitis acute—Cyclosporine—focal segmental glomerulosclerosis	0.00402	0.0174	CcSEcCtD
Tretinoin—Bacterial infection—Cyclosporine—focal segmental glomerulosclerosis	0.00402	0.0174	CcSEcCtD
Tretinoin—Myositis—Cyclosporine—focal segmental glomerulosclerosis	0.00378	0.0164	CcSEcCtD
Tretinoin—CYP3A7-CYP3A51P—cortex of kidney—focal segmental glomerulosclerosis	0.00356	0.0357	CbGeAlD
Tretinoin—Ear disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00344	0.0149	CcSEcCtD
Tretinoin—Hypertriglyceridaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00323	0.014	CcSEcCtD
Tretinoin—Hirsutism—Cyclosporine—focal segmental glomerulosclerosis	0.00319	0.0138	CcSEcCtD
Tretinoin—Gastrointestinal symptom NOS—Cyclosporine—focal segmental glomerulosclerosis	0.00315	0.0136	CcSEcCtD
Tretinoin—Serum creatinine increased—Cyclosporine—focal segmental glomerulosclerosis	0.00301	0.013	CcSEcCtD
Tretinoin—Optic neuritis—Cyclosporine—focal segmental glomerulosclerosis	0.00301	0.013	CcSEcCtD
Tretinoin—GPRC5A—Integrated Pancreatic Cancer Pathway—WT1—focal segmental glomerulosclerosis	0.00297	0.0344	CbGpPWpGaD
Tretinoin—Folliculitis—Cyclosporine—focal segmental glomerulosclerosis	0.00295	0.0128	CcSEcCtD
Tretinoin—Encephalopathy—Cyclosporine—focal segmental glomerulosclerosis	0.00289	0.0125	CcSEcCtD
Tretinoin—Nail disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00286	0.0124	CcSEcCtD
Tretinoin—Blood triglycerides increased—Cyclosporine—focal segmental glomerulosclerosis	0.00283	0.0122	CcSEcCtD
Tretinoin—Menstrual disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00272	0.0118	CcSEcCtD
Tretinoin—Thrombosis—Cyclosporine—focal segmental glomerulosclerosis	0.00262	0.0113	CcSEcCtD
Tretinoin—Hyperlipidaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00257	0.0111	CcSEcCtD
Tretinoin—Hepatotoxicity—Cyclosporine—focal segmental glomerulosclerosis	0.0024	0.0104	CcSEcCtD
Tretinoin—RXRA—Adipogenesis—ZMPSTE24—focal segmental glomerulosclerosis	0.00239	0.0277	CbGpPWpGaD
Tretinoin—Skin ulcer—Cyclosporine—focal segmental glomerulosclerosis	0.00238	0.0103	CcSEcCtD
Tretinoin—Coagulopathy—Cyclosporine—focal segmental glomerulosclerosis	0.00238	0.0103	CcSEcCtD
Tretinoin—Hyperaesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.00236	0.0102	CcSEcCtD
Tretinoin—Gingivitis—Cyclosporine—focal segmental glomerulosclerosis	0.00236	0.0102	CcSEcCtD
Tretinoin—Tingling sensation—Cyclosporine—focal segmental glomerulosclerosis	0.00231	0.00998	CcSEcCtD
Tretinoin—Stinging—Cyclosporine—focal segmental glomerulosclerosis	0.00229	0.0099	CcSEcCtD
Tretinoin—CRABP1—Vitamin A and Carotenoid Metabolism—LPL—focal segmental glomerulosclerosis	0.00221	0.0256	CbGpPWpGaD
Tretinoin—CRABP2—Vitamin A and Carotenoid Metabolism—LPL—focal segmental glomerulosclerosis	0.00221	0.0256	CbGpPWpGaD
Tretinoin—ALDH1A1—Vitamin A and Carotenoid Metabolism—LPL—focal segmental glomerulosclerosis	0.00221	0.0256	CbGpPWpGaD
Tretinoin—Acne—Cyclosporine—focal segmental glomerulosclerosis	0.0022	0.00953	CcSEcCtD
Tretinoin—Neoplasm malignant—Cyclosporine—focal segmental glomerulosclerosis	0.00217	0.00939	CcSEcCtD
Tretinoin—Cardiovascular disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00211	0.00913	CcSEcCtD
Tretinoin—Rhabdomyolysis—Cyclosporine—focal segmental glomerulosclerosis	0.0021	0.00906	CcSEcCtD
Tretinoin—Musculoskeletal stiffness—Cyclosporine—focal segmental glomerulosclerosis	0.00207	0.00894	CcSEcCtD
Tretinoin—Rectal haemorrhage—Cyclosporine—focal segmental glomerulosclerosis	0.00205	0.00888	CcSEcCtD
Tretinoin—Cellulitis—Cyclosporine—focal segmental glomerulosclerosis	0.00204	0.00882	CcSEcCtD
Tretinoin—Lacrimation increased—Cyclosporine—focal segmental glomerulosclerosis	0.00201	0.0087	CcSEcCtD
Tretinoin—Herpes simplex—Cyclosporine—focal segmental glomerulosclerosis	0.00201	0.0087	CcSEcCtD
Tretinoin—Hyperuricaemia—Cyclosporine—focal segmental glomerulosclerosis	0.002	0.00864	CcSEcCtD
Tretinoin—Gout—Cyclosporine—focal segmental glomerulosclerosis	0.00199	0.00859	CcSEcCtD
Tretinoin—Hearing impaired—Cyclosporine—focal segmental glomerulosclerosis	0.00195	0.00842	CcSEcCtD
Tretinoin—Cataract—Cyclosporine—focal segmental glomerulosclerosis	0.00195	0.00842	CcSEcCtD
Tretinoin—Blood uric acid increased—Cyclosporine—focal segmental glomerulosclerosis	0.00189	0.00817	CcSEcCtD
Tretinoin—Hepatocellular injury—Cyclosporine—focal segmental glomerulosclerosis	0.00185	0.00802	CcSEcCtD
Tretinoin—Candida infection—Cyclosporine—focal segmental glomerulosclerosis	0.00177	0.00766	CcSEcCtD
Tretinoin—CYP3A5—nephron tubule—focal segmental glomerulosclerosis	0.00172	0.0173	CbGeAlD
Tretinoin—CYP2B6—nephron tubule—focal segmental glomerulosclerosis	0.00171	0.0172	CbGeAlD
Tretinoin—Oesophagitis—Cyclosporine—focal segmental glomerulosclerosis	0.00169	0.00733	CcSEcCtD
Tretinoin—Coma—Cyclosporine—focal segmental glomerulosclerosis	0.00169	0.00733	CcSEcCtD
Tretinoin—CYP2C8—kidney—focal segmental glomerulosclerosis	0.00168	0.0168	CbGeAlD
Tretinoin—Sepsis—Cyclosporine—focal segmental glomerulosclerosis	0.00161	0.00696	CcSEcCtD
Tretinoin—Lymphadenopathy—Cyclosporine—focal segmental glomerulosclerosis	0.00158	0.00682	CcSEcCtD
Tretinoin—Diabetes mellitus—Cyclosporine—focal segmental glomerulosclerosis	0.00155	0.00669	CcSEcCtD
Tretinoin—CYP1A1—kidney—focal segmental glomerulosclerosis	0.00155	0.0155	CbGeAlD
Tretinoin—CYP3A5—kidney—focal segmental glomerulosclerosis	0.00151	0.0152	CbGeAlD
Tretinoin—Deafness—Cyclosporine—focal segmental glomerulosclerosis	0.0015	0.00651	CcSEcCtD
Tretinoin—CYP2B6—kidney—focal segmental glomerulosclerosis	0.0015	0.0151	CbGeAlD
Tretinoin—GPRC5A—Integrated Pancreatic Cancer Pathway—PCNA—focal segmental glomerulosclerosis	0.0015	0.0174	CbGpPWpGaD
Tretinoin—Eczema—Cyclosporine—focal segmental glomerulosclerosis	0.0015	0.00648	CcSEcCtD
Tretinoin—RARG—Vitamin A and Carotenoid Metabolism—LPL—focal segmental glomerulosclerosis	0.00149	0.0173	CbGpPWpGaD
Tretinoin—CYP3A5—cortex of kidney—focal segmental glomerulosclerosis	0.00147	0.0148	CbGeAlD
Tretinoin—Visual disturbance—Cyclosporine—focal segmental glomerulosclerosis	0.00142	0.00614	CcSEcCtD
Tretinoin—Renal impairment—Cyclosporine—focal segmental glomerulosclerosis	0.00141	0.00612	CcSEcCtD
Tretinoin—Dermatitis bullous—Cyclosporine—focal segmental glomerulosclerosis	0.00141	0.00609	CcSEcCtD
Tretinoin—Arthritis—Cyclosporine—focal segmental glomerulosclerosis	0.00139	0.00599	CcSEcCtD
Tretinoin—Cardiac failure—Cyclosporine—focal segmental glomerulosclerosis	0.00138	0.00596	CcSEcCtD
Tretinoin—Lethargy—Cyclosporine—focal segmental glomerulosclerosis	0.00137	0.00594	CcSEcCtD
Tretinoin—RXRG—Vitamin A and Carotenoid Metabolism—LPL—focal segmental glomerulosclerosis	0.00137	0.0158	CbGpPWpGaD
Tretinoin—Osteoarthritis—Cyclosporine—focal segmental glomerulosclerosis	0.00135	0.00582	CcSEcCtD
Tretinoin—RARB—Vitamin A and Carotenoid Metabolism—LPL—focal segmental glomerulosclerosis	0.00134	0.0155	CbGpPWpGaD
Tretinoin—Affect lability—Cyclosporine—focal segmental glomerulosclerosis	0.00132	0.00573	CcSEcCtD
Tretinoin—RXRA—YAP1- and WWTR1 (TAZ)-stimulated gene expression—CTGF—focal segmental glomerulosclerosis	0.00132	0.0153	CbGpPWpGaD
Tretinoin—RARA—Vitamin A and Carotenoid Metabolism—LPL—focal segmental glomerulosclerosis	0.00128	0.0149	CbGpPWpGaD
Tretinoin—RXRB—Vitamin A and Carotenoid Metabolism—LPL—focal segmental glomerulosclerosis	0.00128	0.0149	CbGpPWpGaD
Tretinoin—Mood swings—Cyclosporine—focal segmental glomerulosclerosis	0.00128	0.00551	CcSEcCtD
Tretinoin—Blood creatinine increased—Cyclosporine—focal segmental glomerulosclerosis	0.00126	0.00545	CcSEcCtD
Tretinoin—NR0B1—Validated nuclear estrogen receptor alpha network—PCNA—focal segmental glomerulosclerosis	0.00125	0.0145	CbGpPWpGaD
Tretinoin—Dry skin—Cyclosporine—focal segmental glomerulosclerosis	0.00123	0.00534	CcSEcCtD
Tretinoin—ALDH1A1—Dopaminergic Neurogenesis—TGFB1—focal segmental glomerulosclerosis	0.00122	0.0142	CbGpPWpGaD
Tretinoin—Gastritis—Cyclosporine—focal segmental glomerulosclerosis	0.00119	0.00515	CcSEcCtD
Tretinoin—Abdominal distension—Cyclosporine—focal segmental glomerulosclerosis	0.00117	0.00506	CcSEcCtD
Tretinoin—Dysphagia—Cyclosporine—focal segmental glomerulosclerosis	0.00116	0.00503	CcSEcCtD
Tretinoin—Acitretin—ALB—focal segmental glomerulosclerosis	0.00115	1	CrCbGaD
Tretinoin—Bronchospasm—Cyclosporine—focal segmental glomerulosclerosis	0.00114	0.00495	CcSEcCtD
Tretinoin—Pancreatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00114	0.00493	CcSEcCtD
Tretinoin—CYP3A4—kidney—focal segmental glomerulosclerosis	0.00114	0.0114	CbGeAlD
Tretinoin—Sweating increased—Cyclosporine—focal segmental glomerulosclerosis	0.00113	0.0049	CcSEcCtD
Tretinoin—RARB—Integrated Pancreatic Cancer Pathway—PIAS1—focal segmental glomerulosclerosis	0.00113	0.0131	CbGpPWpGaD
Tretinoin—Abdominal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.00112	0.00482	CcSEcCtD
Tretinoin—Dysuria—Cyclosporine—focal segmental glomerulosclerosis	0.00109	0.0047	CcSEcCtD
Tretinoin—RARA—Integrated Pancreatic Cancer Pathway—PIAS1—focal segmental glomerulosclerosis	0.00109	0.0126	CbGpPWpGaD
Tretinoin—Upper respiratory tract infection—Cyclosporine—focal segmental glomerulosclerosis	0.00108	0.00468	CcSEcCtD
Tretinoin—Pollakiuria—Cyclosporine—focal segmental glomerulosclerosis	0.00107	0.00465	CcSEcCtD
Tretinoin—Weight increased—Cyclosporine—focal segmental glomerulosclerosis	0.00106	0.00458	CcSEcCtD
Tretinoin—Weight decreased—Cyclosporine—focal segmental glomerulosclerosis	0.00105	0.00455	CcSEcCtD
Tretinoin—Pneumonia—Cyclosporine—focal segmental glomerulosclerosis	0.00104	0.00451	CcSEcCtD
Tretinoin—Infestation NOS—Cyclosporine—focal segmental glomerulosclerosis	0.00104	0.00449	CcSEcCtD
Tretinoin—Infestation—Cyclosporine—focal segmental glomerulosclerosis	0.00104	0.00449	CcSEcCtD
Tretinoin—Depression—Cyclosporine—focal segmental glomerulosclerosis	0.00103	0.00447	CcSEcCtD
Tretinoin—Acute coronary syndrome—Cyclosporine—focal segmental glomerulosclerosis	0.00102	0.00442	CcSEcCtD
Tretinoin—Renal failure—Cyclosporine—focal segmental glomerulosclerosis	0.00102	0.00441	CcSEcCtD
Tretinoin—Myocardial infarction—Cyclosporine—focal segmental glomerulosclerosis	0.00102	0.0044	CcSEcCtD
Tretinoin—Neuropathy peripheral—Cyclosporine—focal segmental glomerulosclerosis	0.00102	0.0044	CcSEcCtD
Tretinoin—CRABP2—Fatty acid, triacylglycerol, and ketone body metabolism—CTGF—focal segmental glomerulosclerosis	0.00101	0.0118	CbGpPWpGaD
Tretinoin—CRABP1—Fatty acid, triacylglycerol, and ketone body metabolism—CTGF—focal segmental glomerulosclerosis	0.00101	0.0118	CbGpPWpGaD
Tretinoin—Stomatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00101	0.00437	CcSEcCtD
Tretinoin—Urinary tract infection—Cyclosporine—focal segmental glomerulosclerosis	0.00101	0.00436	CcSEcCtD
Tretinoin—Conjunctivitis—Cyclosporine—focal segmental glomerulosclerosis	0.00101	0.00436	CcSEcCtD
Tretinoin—Haematuria—Cyclosporine—focal segmental glomerulosclerosis	0.000989	0.00428	CcSEcCtD
Tretinoin—Epistaxis—Cyclosporine—focal segmental glomerulosclerosis	0.000978	0.00423	CcSEcCtD
Tretinoin—Sinusitis—Cyclosporine—focal segmental glomerulosclerosis	0.000973	0.00421	CcSEcCtD
Tretinoin—RXRA—Recycling of bile acids and salts—ALB—focal segmental glomerulosclerosis	0.000969	0.0112	CbGpPWpGaD
Tretinoin—Haemoglobin—Cyclosporine—focal segmental glomerulosclerosis	0.000936	0.00405	CcSEcCtD
Tretinoin—Haemorrhage—Cyclosporine—focal segmental glomerulosclerosis	0.000931	0.00403	CcSEcCtD
Tretinoin—Hepatitis—Cyclosporine—focal segmental glomerulosclerosis	0.000931	0.00403	CcSEcCtD
Tretinoin—RARG—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—focal segmental glomerulosclerosis	0.000928	0.0108	CbGpPWpGaD
Tretinoin—Hypoaesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.000927	0.00401	CcSEcCtD
Tretinoin—Pharyngitis—Cyclosporine—focal segmental glomerulosclerosis	0.000924	0.004	CcSEcCtD
Tretinoin—Urinary tract disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00092	0.00398	CcSEcCtD
Tretinoin—Urethral disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000913	0.00395	CcSEcCtD
Tretinoin—Visual impairment—Cyclosporine—focal segmental glomerulosclerosis	0.000897	0.00388	CcSEcCtD
Tretinoin—Tinnitus—Cyclosporine—focal segmental glomerulosclerosis	0.000868	0.00375	CcSEcCtD
Tretinoin—Flushing—Cyclosporine—focal segmental glomerulosclerosis	0.000864	0.00374	CcSEcCtD
Tretinoin—RXRG—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—focal segmental glomerulosclerosis	0.000848	0.00983	CbGpPWpGaD
Tretinoin—Angiopathy—Cyclosporine—focal segmental glomerulosclerosis	0.000845	0.00365	CcSEcCtD
Tretinoin—Chills—Cyclosporine—focal segmental glomerulosclerosis	0.000836	0.00361	CcSEcCtD
Tretinoin—RARB—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—focal segmental glomerulosclerosis	0.000832	0.00964	CbGpPWpGaD
Tretinoin—Arrhythmia—Cyclosporine—focal segmental glomerulosclerosis	0.000832	0.0036	CcSEcCtD
Tretinoin—Alopecia—Cyclosporine—focal segmental glomerulosclerosis	0.000823	0.00356	CcSEcCtD
Tretinoin—Mental disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000816	0.00353	CcSEcCtD
Tretinoin—Malnutrition—Cyclosporine—focal segmental glomerulosclerosis	0.000811	0.00351	CcSEcCtD
Tretinoin—Flatulence—Cyclosporine—focal segmental glomerulosclerosis	0.000799	0.00345	CcSEcCtD
Tretinoin—RARA—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—focal segmental glomerulosclerosis	0.000798	0.00925	CbGpPWpGaD
Tretinoin—RXRB—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—focal segmental glomerulosclerosis	0.000798	0.00925	CbGpPWpGaD
Tretinoin—Tension—Cyclosporine—focal segmental glomerulosclerosis	0.000795	0.00344	CcSEcCtD
Tretinoin—Nervousness—Cyclosporine—focal segmental glomerulosclerosis	0.000787	0.0034	CcSEcCtD
Tretinoin—Vision blurred—Cyclosporine—focal segmental glomerulosclerosis	0.000764	0.0033	CcSEcCtD
Tretinoin—Tremor—Cyclosporine—focal segmental glomerulosclerosis	0.000759	0.00328	CcSEcCtD
Tretinoin—Ill-defined disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000752	0.00325	CcSEcCtD
Tretinoin—Anaemia—Cyclosporine—focal segmental glomerulosclerosis	0.000749	0.00324	CcSEcCtD
Tretinoin—RARB—Integrated Pancreatic Cancer Pathway—WT1—focal segmental glomerulosclerosis	0.000747	0.00866	CbGpPWpGaD
Tretinoin—Agitation—Cyclosporine—focal segmental glomerulosclerosis	0.000745	0.00322	CcSEcCtD
Tretinoin—Malaise—Cyclosporine—focal segmental glomerulosclerosis	0.000731	0.00316	CcSEcCtD
Tretinoin—RARA—Integrated Pancreatic Cancer Pathway—WT1—focal segmental glomerulosclerosis	0.000716	0.0083	CbGpPWpGaD
Tretinoin—Cough—Cyclosporine—focal segmental glomerulosclerosis	0.000707	0.00306	CcSEcCtD
Tretinoin—Convulsion—Cyclosporine—focal segmental glomerulosclerosis	0.000702	0.00304	CcSEcCtD
Tretinoin—Hypertension—Cyclosporine—focal segmental glomerulosclerosis	0.0007	0.00303	CcSEcCtD
Tretinoin—Myalgia—Cyclosporine—focal segmental glomerulosclerosis	0.00069	0.00298	CcSEcCtD
Tretinoin—Chest pain—Cyclosporine—focal segmental glomerulosclerosis	0.00069	0.00298	CcSEcCtD
Tretinoin—Arthralgia—Cyclosporine—focal segmental glomerulosclerosis	0.00069	0.00298	CcSEcCtD
Tretinoin—Anxiety—Cyclosporine—focal segmental glomerulosclerosis	0.000688	0.00297	CcSEcCtD
Tretinoin—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—focal segmental glomerulosclerosis	0.000685	0.00296	CcSEcCtD
Tretinoin—Discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.000682	0.00295	CcSEcCtD
Tretinoin—Dry mouth—Cyclosporine—focal segmental glomerulosclerosis	0.000675	0.00292	CcSEcCtD
Tretinoin—GPRC5A—Integrated Pancreatic Cancer Pathway—TGFB1—focal segmental glomerulosclerosis	0.000671	0.00778	CbGpPWpGaD
Tretinoin—RXRA—Vitamin A and Carotenoid Metabolism—LPL—focal segmental glomerulosclerosis	0.000669	0.00776	CbGpPWpGaD
Tretinoin—Confusional state—Cyclosporine—focal segmental glomerulosclerosis	0.000667	0.00288	CcSEcCtD
Tretinoin—Oedema—Cyclosporine—focal segmental glomerulosclerosis	0.000662	0.00286	CcSEcCtD
Tretinoin—Anaphylactic shock—Cyclosporine—focal segmental glomerulosclerosis	0.000662	0.00286	CcSEcCtD
Tretinoin—Infection—Cyclosporine—focal segmental glomerulosclerosis	0.000657	0.00284	CcSEcCtD
Tretinoin—Nervous system disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000649	0.00281	CcSEcCtD
Tretinoin—Thrombocytopenia—Cyclosporine—focal segmental glomerulosclerosis	0.000648	0.0028	CcSEcCtD
Tretinoin—Skin disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000643	0.00278	CcSEcCtD
Tretinoin—Hyperhidrosis—Cyclosporine—focal segmental glomerulosclerosis	0.00064	0.00277	CcSEcCtD
Tretinoin—Anorexia—Cyclosporine—focal segmental glomerulosclerosis	0.000631	0.00273	CcSEcCtD
Tretinoin—Musculoskeletal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.000603	0.00261	CcSEcCtD
Tretinoin—CRABP1—Fatty acid, triacylglycerol, and ketone body metabolism—AGT—focal segmental glomerulosclerosis	0.000602	0.00698	CbGpPWpGaD
Tretinoin—CRABP2—Fatty acid, triacylglycerol, and ketone body metabolism—AGT—focal segmental glomerulosclerosis	0.000602	0.00698	CbGpPWpGaD
Tretinoin—Insomnia—Cyclosporine—focal segmental glomerulosclerosis	0.000598	0.00259	CcSEcCtD
Tretinoin—Paraesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.000594	0.00257	CcSEcCtD
Tretinoin—Dyspnoea—Cyclosporine—focal segmental glomerulosclerosis	0.00059	0.00255	CcSEcCtD
Tretinoin—Somnolence—Cyclosporine—focal segmental glomerulosclerosis	0.000588	0.00254	CcSEcCtD
Tretinoin—Dyspepsia—Cyclosporine—focal segmental glomerulosclerosis	0.000582	0.00252	CcSEcCtD
Tretinoin—Decreased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.000575	0.00249	CcSEcCtD
Tretinoin—CYP4A11—PPARA activates gene expression—CTGF—focal segmental glomerulosclerosis	0.000574	0.00666	CbGpPWpGaD
Tretinoin—Gastrointestinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000571	0.00247	CcSEcCtD
Tretinoin—Fatigue—Cyclosporine—focal segmental glomerulosclerosis	0.00057	0.00247	CcSEcCtD
Tretinoin—Pain—Cyclosporine—focal segmental glomerulosclerosis	0.000566	0.00245	CcSEcCtD
Tretinoin—Constipation—Cyclosporine—focal segmental glomerulosclerosis	0.000566	0.00245	CcSEcCtD
Tretinoin—RXRA—Integrated Pancreatic Cancer Pathway—PIAS1—focal segmental glomerulosclerosis	0.000565	0.00656	CbGpPWpGaD
Tretinoin—RXRG—Adipogenesis—LPL—focal segmental glomerulosclerosis	0.000564	0.00654	CbGpPWpGaD
Tretinoin—CYP4A11—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CTGF—focal segmental glomerulosclerosis	0.000562	0.00652	CbGpPWpGaD
Tretinoin—Feeling abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.000545	0.00236	CcSEcCtD
Tretinoin—Gastrointestinal pain—Cyclosporine—focal segmental glomerulosclerosis	0.000541	0.00234	CcSEcCtD
Tretinoin—RARA—Adipogenesis—LPL—focal segmental glomerulosclerosis	0.00053	0.00614	CbGpPWpGaD
Tretinoin—Urticaria—Cyclosporine—focal segmental glomerulosclerosis	0.000526	0.00227	CcSEcCtD
Tretinoin—Body temperature increased—Cyclosporine—focal segmental glomerulosclerosis	0.000523	0.00226	CcSEcCtD
Tretinoin—Abdominal pain—Cyclosporine—focal segmental glomerulosclerosis	0.000523	0.00226	CcSEcCtD
Tretinoin—RXRA—Bile acid and bile salt metabolism—ALB—focal segmental glomerulosclerosis	0.000507	0.00587	CbGpPWpGaD
Tretinoin—RXRA—BMAL1:CLOCK,NPAS2 activates circadian gene expression—SERPINE1—focal segmental glomerulosclerosis	0.000497	0.00576	CbGpPWpGaD
Tretinoin—Hypersensitivity—Cyclosporine—focal segmental glomerulosclerosis	0.000487	0.00211	CcSEcCtD
Tretinoin—RXRG—Adipogenesis—AGT—focal segmental glomerulosclerosis	0.000482	0.00559	CbGpPWpGaD
Tretinoin—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	0.000475	0.00205	CcSEcCtD
Tretinoin—CYP1A1—Melatonin metabolism and effects—EDN1—focal segmental glomerulosclerosis	0.000473	0.00548	CbGpPWpGaD
Tretinoin—Pruritus—Cyclosporine—focal segmental glomerulosclerosis	0.000468	0.00202	CcSEcCtD
Tretinoin—CRABP2—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	0.000459	0.00532	CbGpPWpGaD
Tretinoin—CRABP1—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	0.000459	0.00532	CbGpPWpGaD
Tretinoin—RXRA—PPARA activates gene expression—CTGF—focal segmental glomerulosclerosis	0.000456	0.00528	CbGpPWpGaD
Tretinoin—RARA—Adipogenesis—AGT—focal segmental glomerulosclerosis	0.000453	0.00526	CbGpPWpGaD
Tretinoin—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.000453	0.00196	CcSEcCtD
Tretinoin—RXRA—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CTGF—focal segmental glomerulosclerosis	0.000446	0.00517	CbGpPWpGaD
Tretinoin—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.000438	0.00189	CcSEcCtD
Tretinoin—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	0.000421	0.00182	CcSEcCtD
Tretinoin—RXRA—Transcriptional regulation of white adipocyte differentiation—LPL—focal segmental glomerulosclerosis	0.00042	0.00487	CbGpPWpGaD
Tretinoin—Rash—Cyclosporine—focal segmental glomerulosclerosis	0.000417	0.0018	CcSEcCtD
Tretinoin—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	0.000417	0.0018	CcSEcCtD
Tretinoin—RXRA—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—focal segmental glomerulosclerosis	0.000416	0.00482	CbGpPWpGaD
Tretinoin—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.000414	0.00179	CcSEcCtD
Tretinoin—CRABP2—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	0.000404	0.00468	CbGpPWpGaD
Tretinoin—CRABP1—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	0.000404	0.00468	CbGpPWpGaD
Tretinoin—NR0B1—Generic Transcription Pathway—CTGF—focal segmental glomerulosclerosis	0.000403	0.00467	CbGpPWpGaD
Tretinoin—Nausea—Cyclosporine—focal segmental glomerulosclerosis	0.000393	0.0017	CcSEcCtD
Tretinoin—CYP4A11—Fatty acid, triacylglycerol, and ketone body metabolism—CTGF—focal segmental glomerulosclerosis	0.000387	0.00449	CbGpPWpGaD
Tretinoin—RARB—Integrated Pancreatic Cancer Pathway—PCNA—focal segmental glomerulosclerosis	0.000378	0.00438	CbGpPWpGaD
Tretinoin—RXRA—Integrated Pancreatic Cancer Pathway—WT1—focal segmental glomerulosclerosis	0.000373	0.00433	CbGpPWpGaD
Tretinoin—RXRG—Adipogenesis—SERPINE1—focal segmental glomerulosclerosis	0.000371	0.0043	CbGpPWpGaD
Tretinoin—RARA—Integrated Pancreatic Cancer Pathway—PCNA—focal segmental glomerulosclerosis	0.000362	0.0042	CbGpPWpGaD
Tretinoin—RXRA—Circadian Clock—SERPINE1—focal segmental glomerulosclerosis	0.000362	0.00419	CbGpPWpGaD
Tretinoin—RXRA—Developmental Biology—MYH10—focal segmental glomerulosclerosis	0.000357	0.00414	CbGpPWpGaD
Tretinoin—RARA—Adipogenesis—SERPINE1—focal segmental glomerulosclerosis	0.000349	0.00404	CbGpPWpGaD
Tretinoin—CYP4A11—PPARA activates gene expression—AGT—focal segmental glomerulosclerosis	0.000341	0.00395	CbGpPWpGaD
Tretinoin—CYP4A11—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—AGT—focal segmental glomerulosclerosis	0.000333	0.00386	CbGpPWpGaD
Tretinoin—RARG—Generic Transcription Pathway—CTGF—focal segmental glomerulosclerosis	0.000325	0.00376	CbGpPWpGaD
Tretinoin—CYP1A1—Aryl Hydrocarbon Receptor—LPL—focal segmental glomerulosclerosis	0.000317	0.00368	CbGpPWpGaD
Tretinoin—RXRA—Fatty acid, triacylglycerol, and ketone body metabolism—CTGF—focal segmental glomerulosclerosis	0.000307	0.00356	CbGpPWpGaD
Tretinoin—RXRG—Generic Transcription Pathway—CTGF—focal segmental glomerulosclerosis	0.000297	0.00344	CbGpPWpGaD
Tretinoin—RARB—Generic Transcription Pathway—CTGF—focal segmental glomerulosclerosis	0.000291	0.00338	CbGpPWpGaD
Tretinoin—CRABP2—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	0.00028	0.00325	CbGpPWpGaD
Tretinoin—CRABP1—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	0.00028	0.00325	CbGpPWpGaD
Tretinoin—RXRB—Generic Transcription Pathway—CTGF—focal segmental glomerulosclerosis	0.000279	0.00324	CbGpPWpGaD
Tretinoin—RARA—Generic Transcription Pathway—CTGF—focal segmental glomerulosclerosis	0.000279	0.00324	CbGpPWpGaD
Tretinoin—RXRA—Adipogenesis—LPL—focal segmental glomerulosclerosis	0.000276	0.0032	CbGpPWpGaD
Tretinoin—RXRA—PPARA activates gene expression—AGT—focal segmental glomerulosclerosis	0.00027	0.00313	CbGpPWpGaD
Tretinoin—RXRA—Developmental Biology—COL4A4—focal segmental glomerulosclerosis	0.000264	0.00306	CbGpPWpGaD
Tretinoin—RXRA—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—AGT—focal segmental glomerulosclerosis	0.000264	0.00306	CbGpPWpGaD
Tretinoin—RXRA—Developmental Biology—COL4A1—focal segmental glomerulosclerosis	0.000243	0.00282	CbGpPWpGaD
Tretinoin—CRABP1—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	0.00024	0.00278	CbGpPWpGaD
Tretinoin—CRABP2—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	0.00024	0.00278	CbGpPWpGaD
Tretinoin—RXRA—Adipogenesis—AGT—focal segmental glomerulosclerosis	0.000236	0.00274	CbGpPWpGaD
Tretinoin—RXRG—Adipogenesis—TGFB1—focal segmental glomerulosclerosis	0.000234	0.00271	CbGpPWpGaD
Tretinoin—CYP4A11—Fatty acid, triacylglycerol, and ketone body metabolism—AGT—focal segmental glomerulosclerosis	0.00023	0.00266	CbGpPWpGaD
Tretinoin—CYP1A1—PPARA activates gene expression—CTGF—focal segmental glomerulosclerosis	0.000228	0.00264	CbGpPWpGaD
Tretinoin—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CTGF—focal segmental glomerulosclerosis	0.000223	0.00259	CbGpPWpGaD
Tretinoin—RARA—Adipogenesis—TGFB1—focal segmental glomerulosclerosis	0.00022	0.00255	CbGpPWpGaD
Tretinoin—RXRA—Developmental Biology—COL4A3—focal segmental glomerulosclerosis	0.000205	0.00238	CbGpPWpGaD
Tretinoin—CRABP1—Metabolism—LIPC—focal segmental glomerulosclerosis	0.000204	0.00237	CbGpPWpGaD
Tretinoin—CRABP2—Metabolism—LIPC—focal segmental glomerulosclerosis	0.000204	0.00237	CbGpPWpGaD
Tretinoin—ALDH1A1—Metabolism—LIPC—focal segmental glomerulosclerosis	0.000204	0.00237	CbGpPWpGaD
Tretinoin—RXRA—Developmental Biology—MYH9—focal segmental glomerulosclerosis	0.000196	0.00227	CbGpPWpGaD
Tretinoin—NR0B1—Gene Expression—CTGF—focal segmental glomerulosclerosis	0.000194	0.00225	CbGpPWpGaD
Tretinoin—RXRA—Integrated Pancreatic Cancer Pathway—PCNA—focal segmental glomerulosclerosis	0.000189	0.00219	CbGpPWpGaD
Tretinoin—CRABP2—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	0.000184	0.00213	CbGpPWpGaD
Tretinoin—CRABP1—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	0.000184	0.00213	CbGpPWpGaD
Tretinoin—NR0B1—Generic Transcription Pathway—SERPINE1—focal segmental glomerulosclerosis	0.000184	0.00213	CbGpPWpGaD
Tretinoin—RXRA—Fatty acid, triacylglycerol, and ketone body metabolism—AGT—focal segmental glomerulosclerosis	0.000182	0.00211	CbGpPWpGaD
Tretinoin—RXRA—Adipogenesis—SERPINE1—focal segmental glomerulosclerosis	0.000182	0.00211	CbGpPWpGaD
Tretinoin—CRABP1—Metabolism—CTGF—focal segmental glomerulosclerosis	0.00018	0.00209	CbGpPWpGaD
Tretinoin—CRABP2—Metabolism—CTGF—focal segmental glomerulosclerosis	0.00018	0.00209	CbGpPWpGaD
Tretinoin—ALDH1A1—Metabolism—CTGF—focal segmental glomerulosclerosis	0.00018	0.00209	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	0.000175	0.00203	CbGpPWpGaD
Tretinoin—RXRA—Transcriptional regulation of white adipocyte differentiation—TGFB1—focal segmental glomerulosclerosis	0.000174	0.00202	CbGpPWpGaD
Tretinoin—RARB—Integrated Pancreatic Cancer Pathway—TGFB1—focal segmental glomerulosclerosis	0.000169	0.00196	CbGpPWpGaD
Tretinoin—CRABP1—Metabolism—GNAQ—focal segmental glomerulosclerosis	0.000166	0.00192	CbGpPWpGaD
Tretinoin—CRABP2—Metabolism—GNAQ—focal segmental glomerulosclerosis	0.000166	0.00192	CbGpPWpGaD
Tretinoin—ALDH1A1—Metabolism—GNAQ—focal segmental glomerulosclerosis	0.000166	0.00192	CbGpPWpGaD
Tretinoin—RARA—Integrated Pancreatic Cancer Pathway—TGFB1—focal segmental glomerulosclerosis	0.000162	0.00188	CbGpPWpGaD
Tretinoin—RARG—Gene Expression—CTGF—focal segmental glomerulosclerosis	0.000156	0.00181	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	0.000154	0.00179	CbGpPWpGaD
Tretinoin—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—CTGF—focal segmental glomerulosclerosis	0.000154	0.00178	CbGpPWpGaD
Tretinoin—RXRA—Developmental Biology—TRPC6—focal segmental glomerulosclerosis	0.000151	0.00175	CbGpPWpGaD
Tretinoin—RARG—Generic Transcription Pathway—SERPINE1—focal segmental glomerulosclerosis	0.000148	0.00172	CbGpPWpGaD
Tretinoin—RXRA—Generic Transcription Pathway—CTGF—focal segmental glomerulosclerosis	0.000146	0.00169	CbGpPWpGaD
Tretinoin—RXRG—Gene Expression—CTGF—focal segmental glomerulosclerosis	0.000143	0.00166	CbGpPWpGaD
Tretinoin—RARB—Gene Expression—CTGF—focal segmental glomerulosclerosis	0.00014	0.00163	CbGpPWpGaD
Tretinoin—RXRA—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	0.000139	0.00161	CbGpPWpGaD
Tretinoin—RXRG—Generic Transcription Pathway—SERPINE1—focal segmental glomerulosclerosis	0.000135	0.00157	CbGpPWpGaD
Tretinoin—CYP1A1—PPARA activates gene expression—AGT—focal segmental glomerulosclerosis	0.000135	0.00157	CbGpPWpGaD
Tretinoin—RARA—Gene Expression—CTGF—focal segmental glomerulosclerosis	0.000134	0.00156	CbGpPWpGaD
Tretinoin—RXRB—Gene Expression—CTGF—focal segmental glomerulosclerosis	0.000134	0.00156	CbGpPWpGaD
Tretinoin—RARB—Generic Transcription Pathway—SERPINE1—focal segmental glomerulosclerosis	0.000133	0.00154	CbGpPWpGaD
Tretinoin—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—AGT—focal segmental glomerulosclerosis	0.000132	0.00153	CbGpPWpGaD
Tretinoin—CYP4A11—NRF2 pathway—TGFB1—focal segmental glomerulosclerosis	0.000132	0.00153	CbGpPWpGaD
Tretinoin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—focal segmental glomerulosclerosis	0.000132	0.00153	CbGpPWpGaD
Tretinoin—RXRA—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	0.000128	0.00149	CbGpPWpGaD
Tretinoin—RXRB—Generic Transcription Pathway—SERPINE1—focal segmental glomerulosclerosis	0.000127	0.00148	CbGpPWpGaD
Tretinoin—RARA—Generic Transcription Pathway—SERPINE1—focal segmental glomerulosclerosis	0.000127	0.00148	CbGpPWpGaD
Tretinoin—CRABP2—Metabolism—LPL—focal segmental glomerulosclerosis	0.000125	0.00145	CbGpPWpGaD
Tretinoin—CRABP1—Metabolism—LPL—focal segmental glomerulosclerosis	0.000125	0.00145	CbGpPWpGaD
Tretinoin—ALDH1A1—Metabolism—LPL—focal segmental glomerulosclerosis	0.000125	0.00145	CbGpPWpGaD
Tretinoin—RXRA—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	0.000122	0.00142	CbGpPWpGaD
Tretinoin—RXRA—Adipogenesis—TGFB1—focal segmental glomerulosclerosis	0.000115	0.00133	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	0.000107	0.00124	CbGpPWpGaD
Tretinoin—CRABP2—Metabolism—AGT—focal segmental glomerulosclerosis	0.000107	0.00124	CbGpPWpGaD
Tretinoin—ALDH1A1—Metabolism—AGT—focal segmental glomerulosclerosis	0.000107	0.00124	CbGpPWpGaD
Tretinoin—CRABP1—Metabolism—AGT—focal segmental glomerulosclerosis	0.000107	0.00124	CbGpPWpGaD
Tretinoin—RXRA—NRF2 pathway—TGFB1—focal segmental glomerulosclerosis	0.000105	0.00121	CbGpPWpGaD
Tretinoin—RXRA—Developmental Biology—LPL—focal segmental glomerulosclerosis	9.49e-05	0.0011	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	9.15e-05	0.00106	CbGpPWpGaD
Tretinoin—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—AGT—focal segmental glomerulosclerosis	9.11e-05	0.00106	CbGpPWpGaD
Tretinoin—NR0B1—Gene Expression—SERPINE1—focal segmental glomerulosclerosis	8.84e-05	0.00103	CbGpPWpGaD
Tretinoin—RXRA—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	8.48e-05	0.000983	CbGpPWpGaD
Tretinoin—RXRA—Integrated Pancreatic Cancer Pathway—TGFB1—focal segmental glomerulosclerosis	8.43e-05	0.000977	CbGpPWpGaD
Tretinoin—ALDH1A1—Metabolism—ALB—focal segmental glomerulosclerosis	8.19e-05	0.000949	CbGpPWpGaD
Tretinoin—CRABP1—Metabolism—ALB—focal segmental glomerulosclerosis	8.19e-05	0.000949	CbGpPWpGaD
Tretinoin—CRABP2—Metabolism—ALB—focal segmental glomerulosclerosis	8.19e-05	0.000949	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—LIPC—focal segmental glomerulosclerosis	7.8e-05	0.000904	CbGpPWpGaD
Tretinoin—RXRA—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	7.25e-05	0.000841	CbGpPWpGaD
Tretinoin—RARG—Gene Expression—SERPINE1—focal segmental glomerulosclerosis	7.13e-05	0.000826	CbGpPWpGaD
Tretinoin—CYP2A6—NRF2 pathway—TGFB1—focal segmental glomerulosclerosis	7.02e-05	0.000814	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	7.02e-05	0.000814	CbGpPWpGaD
Tretinoin—RXRA—Gene Expression—CTGF—focal segmental glomerulosclerosis	7.01e-05	0.000812	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	6.95e-05	0.000806	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—CTGF—focal segmental glomerulosclerosis	6.87e-05	0.000796	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—LIPC—focal segmental glomerulosclerosis	6.82e-05	0.000791	CbGpPWpGaD
Tretinoin—RXRA—Generic Transcription Pathway—SERPINE1—focal segmental glomerulosclerosis	6.63e-05	0.000769	CbGpPWpGaD
Tretinoin—RXRG—Gene Expression—SERPINE1—focal segmental glomerulosclerosis	6.52e-05	0.000756	CbGpPWpGaD
Tretinoin—RARB—Gene Expression—SERPINE1—focal segmental glomerulosclerosis	6.39e-05	0.000741	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	6.37e-05	0.000739	CbGpPWpGaD
Tretinoin—RXRA—Developmental Biology—MMP2—focal segmental glomerulosclerosis	6.36e-05	0.000738	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—GNAQ—focal segmental glomerulosclerosis	6.33e-05	0.000734	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—LIPC—focal segmental glomerulosclerosis	6.19e-05	0.000717	CbGpPWpGaD
Tretinoin—RXRB—Gene Expression—SERPINE1—focal segmental glomerulosclerosis	6.13e-05	0.000711	CbGpPWpGaD
Tretinoin—RARA—Gene Expression—SERPINE1—focal segmental glomerulosclerosis	6.13e-05	0.000711	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	6.12e-05	0.00071	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—CTGF—focal segmental glomerulosclerosis	6e-05	0.000696	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	5.61e-05	0.00065	CbGpPWpGaD
Tretinoin—RXRA—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	5.57e-05	0.000645	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—GNAQ—focal segmental glomerulosclerosis	5.53e-05	0.000641	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—CTGF—focal segmental glomerulosclerosis	5.45e-05	0.000632	CbGpPWpGaD
Tretinoin—RXRA—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	5.29e-05	0.000614	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	5.19e-05	0.000601	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—GNAQ—focal segmental glomerulosclerosis	5.02e-05	0.000582	CbGpPWpGaD
Tretinoin—RXRA—Developmental Biology—MMP9—focal segmental glomerulosclerosis	4.78e-05	0.000555	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—LPL—focal segmental glomerulosclerosis	4.76e-05	0.000552	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	4.57e-05	0.000529	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—LIPC—focal segmental glomerulosclerosis	4.53e-05	0.000526	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	4.24e-05	0.000492	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—LPL—focal segmental glomerulosclerosis	4.16e-05	0.000482	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—LIPC—focal segmental glomerulosclerosis	4.16e-05	0.000482	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—AGT—focal segmental glomerulosclerosis	4.07e-05	0.000472	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—CTGF—focal segmental glomerulosclerosis	3.99e-05	0.000463	CbGpPWpGaD
Tretinoin—RXRA—Developmental Biology—TGFB1—focal segmental glomerulosclerosis	3.94e-05	0.000457	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	3.89e-05	0.000451	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—LPL—focal segmental glomerulosclerosis	3.78e-05	0.000438	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—GNAQ—focal segmental glomerulosclerosis	3.68e-05	0.000426	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—CTGF—focal segmental glomerulosclerosis	3.66e-05	0.000424	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	3.63e-05	0.000421	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—AGT—focal segmental glomerulosclerosis	3.56e-05	0.000413	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—GNAQ—focal segmental glomerulosclerosis	3.37e-05	0.000391	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—LIPC—focal segmental glomerulosclerosis	3.35e-05	0.000389	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	3.33e-05	0.000386	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—LIPC—focal segmental glomerulosclerosis	3.28e-05	0.00038	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—AGT—focal segmental glomerulosclerosis	3.23e-05	0.000374	CbGpPWpGaD
Tretinoin—RXRA—Gene Expression—SERPINE1—focal segmental glomerulosclerosis	3.19e-05	0.00037	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	3.17e-05	0.000367	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—ALB—focal segmental glomerulosclerosis	3.13e-05	0.000362	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—LIPC—focal segmental glomerulosclerosis	3.1e-05	0.000359	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—CTGF—focal segmental glomerulosclerosis	2.95e-05	0.000342	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—CTGF—focal segmental glomerulosclerosis	2.89e-05	0.000334	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—LIPC—focal segmental glomerulosclerosis	2.84e-05	0.000329	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	2.79e-05	0.000323	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—LPL—focal segmental glomerulosclerosis	2.77e-05	0.000321	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—ALB—focal segmental glomerulosclerosis	2.73e-05	0.000317	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—CTGF—focal segmental glomerulosclerosis	2.73e-05	0.000316	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—GNAQ—focal segmental glomerulosclerosis	2.72e-05	0.000315	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	2.71e-05	0.000314	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—GNAQ—focal segmental glomerulosclerosis	2.66e-05	0.000308	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	2.55e-05	0.000296	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—LPL—focal segmental glomerulosclerosis	2.54e-05	0.000294	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—GNAQ—focal segmental glomerulosclerosis	2.51e-05	0.000291	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—CTGF—focal segmental glomerulosclerosis	2.5e-05	0.00029	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—ALB—focal segmental glomerulosclerosis	2.48e-05	0.000287	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—AGT—focal segmental glomerulosclerosis	2.37e-05	0.000274	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—LIPC—focal segmental glomerulosclerosis	2.31e-05	0.000268	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—GNAQ—focal segmental glomerulosclerosis	2.3e-05	0.000267	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—AGT—focal segmental glomerulosclerosis	2.17e-05	0.000251	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	2.08e-05	0.000241	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—LPL—focal segmental glomerulosclerosis	2.05e-05	0.000237	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—CTGF—focal segmental glomerulosclerosis	2.03e-05	0.000236	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—LPL—focal segmental glomerulosclerosis	2e-05	0.000232	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—LPL—focal segmental glomerulosclerosis	1.89e-05	0.000219	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.87e-05	0.000217	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—ALB—focal segmental glomerulosclerosis	1.82e-05	0.000211	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—AGT—focal segmental glomerulosclerosis	1.75e-05	0.000203	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—LPL—focal segmental glomerulosclerosis	1.73e-05	0.000201	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—AGT—focal segmental glomerulosclerosis	1.71e-05	0.000198	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—ALB—focal segmental glomerulosclerosis	1.66e-05	0.000193	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—AGT—focal segmental glomerulosclerosis	1.62e-05	0.000187	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—LIPC—focal segmental glomerulosclerosis	1.52e-05	0.000177	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—AGT—focal segmental glomerulosclerosis	1.48e-05	0.000172	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—LPL—focal segmental glomerulosclerosis	1.41e-05	0.000163	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—ALB—focal segmental glomerulosclerosis	1.34e-05	0.000156	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—CTGF—focal segmental glomerulosclerosis	1.34e-05	0.000155	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—ALB—focal segmental glomerulosclerosis	1.31e-05	0.000152	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—ALB—focal segmental glomerulosclerosis	1.24e-05	0.000144	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.24e-05	0.000143	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—AGT—focal segmental glomerulosclerosis	1.21e-05	0.00014	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—ALB—focal segmental glomerulosclerosis	1.14e-05	0.000132	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—LPL—focal segmental glomerulosclerosis	9.3e-06	0.000108	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—ALB—focal segmental glomerulosclerosis	9.26e-06	0.000107	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—AGT—focal segmental glomerulosclerosis	7.95e-06	9.22e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—ALB—focal segmental glomerulosclerosis	6.1e-06	7.08e-05	CbGpPWpGaD
